TrialMicrobiology spectrum2022

Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.

Jeffrey M Sturek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.